Euroespes S.A. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2011
2012
2013
2014
2015
Net Income before Extraordinaries
25.90
652.30
29.80
179.00
190.80
Depreciation, Depletion & Amortization
189.90
206.70
200.40
206.40
298.80
Other Funds
9.20
480.70
0.70
14.90
32.20
Funds from Operations
154.80
35.20
231.00
400.20
521.80
Changes in Working Capital
155.30
62.30
21.00
308.40
106.90
Net Operating Cash Flow
310.10
97.50
210.00
91.90
414.90
Capital Expenditures
140.70
157.10
399.90
331.70
607.20
Net Investing Cash Flow
140.70
157.10
399.90
331.70
607.20
Cash Dividends Paid - Total
2.50
-
-
-
-
Issuance/Reduction of Debt, Net
179.00
102.30
348.70
922.90
25.60
Net Financing Cash Flow
286.90
178.80
356.40
163.90
105.30
Net Change in Cash
117.50
238.50
166.60
75.90
87.00
Free Cash Flow
251.40
22.10
108.50
51.10
184.90
Change in Capital Stock
105.30
76.50
7.70
759.00
130.90

About Euroespes

View Profile
Address
Biomedical Research Center
Bergondo Galicia 15165
Spain
Employees -
Website http://www.euroespes.com
Updated 07/08/2019
EuroEspes SA engages in the provision of biomedical services. It also engages in the design and implementation of prevention programs for diseases of the central nervous system. Its business model involves investigating possible causes of central nervous system disorders.